Journal article · 2026 · Open access
PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY
Journal of Biomedical and Techno Nanomaterials, 3(2), 86–97 · Published 4 April 2026 · DOI 10.70177/jbtn.v3i2.3211
In brief
“PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY” is a 2026 journal article by Fatima Ahmed and 2 co-authors, published in Journal of Biomedical and Techno Nanomaterials. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-SA licence: the full text is free to read at Journal of Biomedical and Techno Nanomaterials.
- Citations
- 0
- References
- 38
- Authors
- 3
Abstract
Pharmaceutical nanotechnology has emerged as a promising approach to enhance the bioavailability and therapeutic efficacy of drugs. Many drugs suffer from poor solubility, limited absorption, and rapid metabolism, leading to suboptimal therapeutic outcomes. Nanotechnology-based drug delivery systems offer solutions to these challenges by improving the stability, solubility, and controlled release of pharmaceuticals. This study explores the use of nanotechnology in the design and development of drug delivery systems aimed at enhancing bioavailability and optimizing therapeutic efficacy. The primary objective is to evaluate the effectiveness of various nanocarriers, including liposomes, dendrimers, and polymeric nanoparticles, in improving drug solubility and ensuring targeted delivery. The research employs in vitro and in vivo models to assess drug release profiles, absorption rates, and pharmacokinetic properties. The results demonstrate that nanotechnology-based systems significantly improve drug bioavailability and extend therapeutic efficacy by providing controlled and sustained drug release, reducing side effects, and enhancing cellular uptake. In conclusion, pharmaceutical nanotechnology offers a powerful strategy to overcome the limitations of conventional drug delivery systems, providing a pathway for more effective treatments in various therapeutic areas.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ahmed, F., Omar, A., & Muntasir, M. (2026). PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY. Journal of Biomedical and Techno Nanomaterials, 3(2), 86–97. https://doi.org/10.70177/jbtn.v3i2.3211
MLA 9
Ahmed, Fatima, et al. “PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY.” Journal of Biomedical and Techno Nanomaterials, vol. 3, no. 2, 2026, pp. 86–97. https://doi.org/10.70177/jbtn.v3i2.3211.
Chicago
Ahmed, Fatima, Ali Omar, and Muntasir Muntasir. 2026. “PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY.” Journal of Biomedical and Techno Nanomaterials 3 (2): 86–97. https://doi.org/10.70177/jbtn.v3i2.3211.
Harvard
Ahmed, F., Omar, A. and Muntasir, M. (2026) ‘PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY’, Journal of Biomedical and Techno Nanomaterials, 3(2), pp. 86–97. doi:10.70177/jbtn.v3i2.3211.
IEEE
F. Ahmed, A. Omar, and M. Muntasir, “PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY,” Journal of Biomedical and Techno Nanomaterials, vol. 3, no. 2, pp. 86–97, 2026, doi: 10.70177/jbtn.v3i2.3211.
BibTeX
@article{ahmed2026pharmaceutical,
title = {{PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY}},
author = {Ahmed, Fatima and Omar, Ali and Muntasir, Muntasir},
journal = {Journal of Biomedical and Techno Nanomaterials},
year = {2026},
volume = {3},
number = {2},
pages = {86--97},
doi = {10.70177/jbtn.v3i2.3211},
url = {https://doi.org/10.70177/jbtn.v3i2.3211}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pharmaceutical nanotechnology
- drug bioavailability
- drug delivery systems
- nanocarriers
- liposomes
- dendrimers
- polymeric nanoparticles
- drug solubility
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Ahmed, F., Omar, A., & Muntasir, M. (2026). PHARMACEUTICAL NANOTECHNOLOGY FOR IMPROVING BIOAVAILABILITY AND THERAPEUTIC EFFICACY. Journal of Biomedical and Techno Nanomaterials, 3(2), 86–97. https://doi.org/10.70177/jbtn.v3i2.3211
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of Biomedical and Techno Nanomaterials.
Who wrote this paper?
Fatima Ahmed, Ali Omar, Muntasir Muntasir.
What is the DOI of this paper?
10.70177/jbtn.v3i2.3211. The permanent link is https://doi.org/10.70177/jbtn.v3i2.3211.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.